Search All News
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment.
- December 10, 2018
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
- December 10, 2018
A new study suggests that a type of brain tumor in patients with neurofibromatosis type 1 could be treated with immunotherapy, which has so far proved ineffective in treating most brain cancers.
- October 31, 2018
A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.
- October 12, 2018
For the second year, Velocity, Columbia's Ride to End Cancer raised more than $1 million for cancer care and research.
- September 28, 2018
Sarah Urke and Barbara Trencher, Columbia physical therapists and Velocity participants, developed an exercise program for cancer patients.
- September 20, 2018
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
- August 27, 2018
Physician-scientist Darrell Yamashiro, MD, PhD, has been named director of Columbia's Division of Pediatric Hematology, Oncology, & Stem Cell Transplantation.
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
- July 10, 2018
Acupuncture significantly eased joint pain for a majority of women undergoing a common form of breast cancer treatment, a new study found.